nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A1—Estropipate—osteoporosis	0.107	0.155	CbGbCtD
Desipramine—SLC22A3—Estradiol—osteoporosis	0.0862	0.125	CbGbCtD
Desipramine—SLC22A2—Estradiol—osteoporosis	0.051	0.0742	CbGbCtD
Desipramine—SLC22A1—Estradiol—osteoporosis	0.0443	0.0645	CbGbCtD
Desipramine—CYP2B6—Raloxifene—osteoporosis	0.0426	0.0619	CbGbCtD
Desipramine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0411	0.0598	CbGbCtD
Desipramine—CYP1A2—Estropipate—osteoporosis	0.0374	0.0544	CbGbCtD
Desipramine—CYP2B6—Cholecalciferol—osteoporosis	0.0329	0.0478	CbGbCtD
Desipramine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0211	0.0307	CbGbCtD
Desipramine—CYP2C19—Cholecalciferol—osteoporosis	0.0209	0.0304	CbGbCtD
Desipramine—CYP3A4—Estropipate—osteoporosis	0.0196	0.0285	CbGbCtD
Desipramine—CYP3A4—Calcitriol—osteoporosis	0.0196	0.0285	CbGbCtD
Desipramine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0177	0.0257	CbGbCtD
Desipramine—CYP2C19—Estradiol—osteoporosis	0.0168	0.0245	CbGbCtD
Desipramine—CYP2D6—Cholecalciferol—osteoporosis	0.0159	0.0231	CbGbCtD
Desipramine—CYP3A4—Ergocalciferol—osteoporosis	0.0157	0.0228	CbGbCtD
Desipramine—CYP1A2—Estradiol—osteoporosis	0.0155	0.0226	CbGbCtD
Desipramine—ABCB1—Conjugated Estrogens—osteoporosis	0.0155	0.0225	CbGbCtD
Desipramine—ABCB1—Estradiol—osteoporosis	0.0136	0.0198	CbGbCtD
Desipramine—CYP3A4—Raloxifene—osteoporosis	0.0131	0.019	CbGbCtD
Desipramine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0126	0.0184	CbGbCtD
Desipramine—CYP3A4—Cholecalciferol—osteoporosis	0.0101	0.0147	CbGbCtD
Desipramine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00927	0.0135	CbGbCtD
Desipramine—CYP3A4—Estradiol—osteoporosis	0.00814	0.0118	CbGbCtD
Desipramine—Benazepril—MTHFR—osteoporosis	0.000819	0.551	CrCbGaD
Desipramine—Benazepril—ACE—osteoporosis	0.000668	0.449	CrCbGaD
Desipramine—Constipation—Alendronate—osteoporosis	0.000437	0.00203	CcSEcCtD
Desipramine—Hypertension—Risedronate—osteoporosis	0.000434	0.00202	CcSEcCtD
Desipramine—Discomfort—Ethinyl Estradiol—osteoporosis	0.000434	0.00201	CcSEcCtD
Desipramine—Somnolence—Calcitriol—osteoporosis	0.000433	0.00201	CcSEcCtD
Desipramine—Decreased appetite—Ibandronate—osteoporosis	0.000433	0.00201	CcSEcCtD
Desipramine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000431	0.002	CcSEcCtD
Desipramine—Malaise—Pamidronate—osteoporosis	0.000431	0.002	CcSEcCtD
Desipramine—Depression—Estradiol—osteoporosis	0.000429	0.00199	CcSEcCtD
Desipramine—Fatigue—Ibandronate—osteoporosis	0.000429	0.00199	CcSEcCtD
Desipramine—Dysgeusia—Zoledronate—osteoporosis	0.000427	0.00198	CcSEcCtD
Desipramine—Alopecia—Conjugated Estrogens—osteoporosis	0.000427	0.00198	CcSEcCtD
Desipramine—Anxiety—Risedronate—osteoporosis	0.000426	0.00198	CcSEcCtD
Desipramine—Constipation—Ibandronate—osteoporosis	0.000426	0.00198	CcSEcCtD
Desipramine—Pruritus—Etidronic acid—osteoporosis	0.000424	0.00197	CcSEcCtD
Desipramine—Acute coronary syndrome—Estradiol—osteoporosis	0.000424	0.00197	CcSEcCtD
Desipramine—Decreased appetite—Calcitriol—osteoporosis	0.000424	0.00197	CcSEcCtD
Desipramine—Myocardial infarction—Estradiol—osteoporosis	0.000422	0.00196	CcSEcCtD
Desipramine—Neuropathy peripheral—Estradiol—osteoporosis	0.000422	0.00196	CcSEcCtD
Desipramine—Feeling abnormal—Alendronate—osteoporosis	0.000421	0.00196	CcSEcCtD
Desipramine—Oedema—Ethinyl Estradiol—osteoporosis	0.000421	0.00195	CcSEcCtD
Desipramine—Jaundice—Estradiol—osteoporosis	0.000419	0.00195	CcSEcCtD
Desipramine—Dry mouth—Risedronate—osteoporosis	0.000418	0.00194	CcSEcCtD
Desipramine—Constipation—Calcitriol—osteoporosis	0.000417	0.00194	CcSEcCtD
Desipramine—Convulsion—Pamidronate—osteoporosis	0.000414	0.00192	CcSEcCtD
Desipramine—Hypertension—Pamidronate—osteoporosis	0.000412	0.00192	CcSEcCtD
Desipramine—Urticaria—Estropipate—osteoporosis	0.000412	0.00191	CcSEcCtD
Desipramine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000412	0.00191	CcSEcCtD
Desipramine—Vision blurred—Zoledronate—osteoporosis	0.000411	0.00191	CcSEcCtD
Desipramine—Diarrhoea—Etidronic acid—osteoporosis	0.00041	0.00191	CcSEcCtD
Desipramine—Body temperature increased—Estropipate—osteoporosis	0.00041	0.00191	CcSEcCtD
Desipramine—Abdominal pain—Estropipate—osteoporosis	0.00041	0.00191	CcSEcCtD
Desipramine—Feeling abnormal—Ibandronate—osteoporosis	0.00041	0.0019	CcSEcCtD
Desipramine—Tremor—Zoledronate—osteoporosis	0.000409	0.0019	CcSEcCtD
Desipramine—Urticaria—Alendronate—osteoporosis	0.000406	0.00189	CcSEcCtD
Desipramine—Anxiety—Pamidronate—osteoporosis	0.000405	0.00188	CcSEcCtD
Desipramine—Ill-defined disorder—Zoledronate—osteoporosis	0.000405	0.00188	CcSEcCtD
Desipramine—Abdominal pain—Alendronate—osteoporosis	0.000404	0.00188	CcSEcCtD
Desipramine—Body temperature increased—Alendronate—osteoporosis	0.000404	0.00188	CcSEcCtD
Desipramine—Discomfort—Pamidronate—osteoporosis	0.000402	0.00187	CcSEcCtD
Desipramine—Agitation—Zoledronate—osteoporosis	0.000401	0.00186	CcSEcCtD
Desipramine—Abdominal pain—Raloxifene—osteoporosis	0.000397	0.00185	CcSEcCtD
Desipramine—Body temperature increased—Raloxifene—osteoporosis	0.000397	0.00185	CcSEcCtD
Desipramine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000396	0.00184	CcSEcCtD
Desipramine—Urticaria—Ibandronate—osteoporosis	0.000395	0.00184	CcSEcCtD
Desipramine—Malaise—Zoledronate—osteoporosis	0.000394	0.00183	CcSEcCtD
Desipramine—Body temperature increased—Ibandronate—osteoporosis	0.000393	0.00183	CcSEcCtD
Desipramine—Abdominal pain—Ibandronate—osteoporosis	0.000393	0.00183	CcSEcCtD
Desipramine—Confusional state—Pamidronate—osteoporosis	0.000393	0.00183	CcSEcCtD
Desipramine—Oedema—Pamidronate—osteoporosis	0.00039	0.00181	CcSEcCtD
Desipramine—Urticaria—Calcitriol—osteoporosis	0.000387	0.0018	CcSEcCtD
Desipramine—Hepatitis—Estradiol—osteoporosis	0.000386	0.00179	CcSEcCtD
Desipramine—Palpitations—Zoledronate—osteoporosis	0.000386	0.00179	CcSEcCtD
Desipramine—Abdominal pain—Calcitriol—osteoporosis	0.000385	0.00179	CcSEcCtD
Desipramine—Body temperature increased—Calcitriol—osteoporosis	0.000385	0.00179	CcSEcCtD
Desipramine—Hypoaesthesia—Estradiol—osteoporosis	0.000384	0.00179	CcSEcCtD
Desipramine—Thrombocytopenia—Pamidronate—osteoporosis	0.000382	0.00177	CcSEcCtD
Desipramine—Vomiting—Etidronic acid—osteoporosis	0.000381	0.00177	CcSEcCtD
Desipramine—Tachycardia—Pamidronate—osteoporosis	0.000381	0.00177	CcSEcCtD
Desipramine—Rash—Etidronic acid—osteoporosis	0.000378	0.00176	CcSEcCtD
Desipramine—Convulsion—Zoledronate—osteoporosis	0.000378	0.00176	CcSEcCtD
Desipramine—Dermatitis—Etidronic acid—osteoporosis	0.000378	0.00176	CcSEcCtD
Desipramine—Hypertension—Zoledronate—osteoporosis	0.000377	0.00175	CcSEcCtD
Desipramine—Headache—Etidronic acid—osteoporosis	0.000376	0.00175	CcSEcCtD
Desipramine—Asthenia—Estropipate—osteoporosis	0.000372	0.00173	CcSEcCtD
Desipramine—Anorexia—Pamidronate—osteoporosis	0.000372	0.00173	CcSEcCtD
Desipramine—Palpitations—Conjugated Estrogens—osteoporosis	0.000371	0.00172	CcSEcCtD
Desipramine—Insomnia—Risedronate—osteoporosis	0.000371	0.00172	CcSEcCtD
Desipramine—Anxiety—Zoledronate—osteoporosis	0.00037	0.00172	CcSEcCtD
Desipramine—Paraesthesia—Risedronate—osteoporosis	0.000368	0.00171	CcSEcCtD
Desipramine—Pruritus—Estropipate—osteoporosis	0.000367	0.00171	CcSEcCtD
Desipramine—Discomfort—Zoledronate—osteoporosis	0.000367	0.0017	CcSEcCtD
Desipramine—Asthenia—Alendronate—osteoporosis	0.000367	0.0017	CcSEcCtD
Desipramine—Hypotension—Pamidronate—osteoporosis	0.000364	0.00169	CcSEcCtD
Desipramine—Convulsion—Conjugated Estrogens—osteoporosis	0.000364	0.00169	CcSEcCtD
Desipramine—Dry mouth—Zoledronate—osteoporosis	0.000363	0.00169	CcSEcCtD
Desipramine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000363	0.00168	CcSEcCtD
Desipramine—Pruritus—Alendronate—osteoporosis	0.000362	0.00168	CcSEcCtD
Desipramine—Dyspepsia—Risedronate—osteoporosis	0.000361	0.00168	CcSEcCtD
Desipramine—Tinnitus—Estradiol—osteoporosis	0.00036	0.00167	CcSEcCtD
Desipramine—Constipation—Ethinyl Estradiol—osteoporosis	0.00036	0.00167	CcSEcCtD
Desipramine—Confusional state—Zoledronate—osteoporosis	0.000359	0.00167	CcSEcCtD
Desipramine—Flushing—Estradiol—osteoporosis	0.000359	0.00167	CcSEcCtD
Desipramine—Asthenia—Ibandronate—osteoporosis	0.000357	0.00166	CcSEcCtD
Desipramine—Anxiety—Conjugated Estrogens—osteoporosis	0.000357	0.00166	CcSEcCtD
Desipramine—Nausea—Etidronic acid—osteoporosis	0.000356	0.00166	CcSEcCtD
Desipramine—Oedema—Zoledronate—osteoporosis	0.000356	0.00165	CcSEcCtD
Desipramine—Diarrhoea—Estropipate—osteoporosis	0.000355	0.00165	CcSEcCtD
Desipramine—Fatigue—Risedronate—osteoporosis	0.000354	0.00164	CcSEcCtD
Desipramine—Insomnia—Pamidronate—osteoporosis	0.000353	0.00164	CcSEcCtD
Desipramine—Pruritus—Ibandronate—osteoporosis	0.000352	0.00164	CcSEcCtD
Desipramine—Constipation—Risedronate—osteoporosis	0.000351	0.00163	CcSEcCtD
Desipramine—Paraesthesia—Pamidronate—osteoporosis	0.00035	0.00163	CcSEcCtD
Desipramine—Diarrhoea—Alendronate—osteoporosis	0.00035	0.00162	CcSEcCtD
Desipramine—Asthenia—Calcitriol—osteoporosis	0.00035	0.00162	CcSEcCtD
Desipramine—Thrombocytopenia—Zoledronate—osteoporosis	0.000349	0.00162	CcSEcCtD
Desipramine—Tachycardia—Zoledronate—osteoporosis	0.000348	0.00161	CcSEcCtD
Desipramine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000347	0.00161	CcSEcCtD
Desipramine—Somnolence—Pamidronate—osteoporosis	0.000347	0.00161	CcSEcCtD
Desipramine—Pruritus—Calcitriol—osteoporosis	0.000345	0.0016	CcSEcCtD
Desipramine—Diarrhoea—Raloxifene—osteoporosis	0.000344	0.0016	CcSEcCtD
Desipramine—Dyspepsia—Pamidronate—osteoporosis	0.000343	0.00159	CcSEcCtD
Desipramine—Dizziness—Estropipate—osteoporosis	0.000343	0.00159	CcSEcCtD
Desipramine—Oedema—Conjugated Estrogens—osteoporosis	0.000343	0.00159	CcSEcCtD
Desipramine—Alopecia—Estradiol—osteoporosis	0.000341	0.00159	CcSEcCtD
Desipramine—Diarrhoea—Ibandronate—osteoporosis	0.000341	0.00158	CcSEcCtD
Desipramine—Anorexia—Zoledronate—osteoporosis	0.00034	0.00158	CcSEcCtD
Desipramine—Decreased appetite—Pamidronate—osteoporosis	0.000339	0.00157	CcSEcCtD
Desipramine—Dizziness—Alendronate—osteoporosis	0.000338	0.00157	CcSEcCtD
Desipramine—Fatigue—Pamidronate—osteoporosis	0.000336	0.00156	CcSEcCtD
Desipramine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000335	0.00155	CcSEcCtD
Desipramine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000334	0.00155	CcSEcCtD
Desipramine—Constipation—Pamidronate—osteoporosis	0.000333	0.00155	CcSEcCtD
Desipramine—Diarrhoea—Calcitriol—osteoporosis	0.000333	0.00155	CcSEcCtD
Desipramine—Hypotension—Zoledronate—osteoporosis	0.000333	0.00155	CcSEcCtD
Desipramine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000333	0.00154	CcSEcCtD
Desipramine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000333	0.00154	CcSEcCtD
Desipramine—Dizziness—Raloxifene—osteoporosis	0.000332	0.00154	CcSEcCtD
Desipramine—Vomiting—Estropipate—osteoporosis	0.00033	0.00153	CcSEcCtD
Desipramine—Dysgeusia—Estradiol—osteoporosis	0.000329	0.00153	CcSEcCtD
Desipramine—Dizziness—Ibandronate—osteoporosis	0.000329	0.00153	CcSEcCtD
Desipramine—Rash—Estropipate—osteoporosis	0.000327	0.00152	CcSEcCtD
Desipramine—Dermatitis—Estropipate—osteoporosis	0.000327	0.00152	CcSEcCtD
Desipramine—Anorexia—Conjugated Estrogens—osteoporosis	0.000327	0.00152	CcSEcCtD
Desipramine—Urticaria—Risedronate—osteoporosis	0.000326	0.00151	CcSEcCtD
Desipramine—Headache—Estropipate—osteoporosis	0.000325	0.00151	CcSEcCtD
Desipramine—Vomiting—Alendronate—osteoporosis	0.000325	0.00151	CcSEcCtD
Desipramine—Body temperature increased—Risedronate—osteoporosis	0.000324	0.00151	CcSEcCtD
Desipramine—Abdominal pain—Risedronate—osteoporosis	0.000324	0.00151	CcSEcCtD
Desipramine—Rash—Alendronate—osteoporosis	0.000322	0.0015	CcSEcCtD
Desipramine—Insomnia—Zoledronate—osteoporosis	0.000322	0.0015	CcSEcCtD
Desipramine—Dermatitis—Alendronate—osteoporosis	0.000322	0.0015	CcSEcCtD
Desipramine—Feeling abnormal—Pamidronate—osteoporosis	0.000321	0.00149	CcSEcCtD
Desipramine—Hypotension—Conjugated Estrogens—osteoporosis	0.00032	0.00149	CcSEcCtD
Desipramine—Headache—Alendronate—osteoporosis	0.00032	0.00149	CcSEcCtD
Desipramine—Paraesthesia—Zoledronate—osteoporosis	0.00032	0.00149	CcSEcCtD
Desipramine—Vomiting—Raloxifene—osteoporosis	0.00032	0.00148	CcSEcCtD
Desipramine—Rash—Raloxifene—osteoporosis	0.000317	0.00147	CcSEcCtD
Desipramine—Dermatitis—Raloxifene—osteoporosis	0.000317	0.00147	CcSEcCtD
Desipramine—Somnolence—Zoledronate—osteoporosis	0.000317	0.00147	CcSEcCtD
Desipramine—Vomiting—Ibandronate—osteoporosis	0.000316	0.00147	CcSEcCtD
Desipramine—Tremor—Estradiol—osteoporosis	0.000315	0.00146	CcSEcCtD
Desipramine—Headache—Raloxifene—osteoporosis	0.000315	0.00146	CcSEcCtD
Desipramine—Rash—Ibandronate—osteoporosis	0.000314	0.00146	CcSEcCtD
Desipramine—Dermatitis—Ibandronate—osteoporosis	0.000314	0.00146	CcSEcCtD
Desipramine—Dyspepsia—Zoledronate—osteoporosis	0.000314	0.00146	CcSEcCtD
Desipramine—Ill-defined disorder—Estradiol—osteoporosis	0.000312	0.00145	CcSEcCtD
Desipramine—Headache—Ibandronate—osteoporosis	0.000312	0.00145	CcSEcCtD
Desipramine—Insomnia—Conjugated Estrogens—osteoporosis	0.00031	0.00144	CcSEcCtD
Desipramine—Vomiting—Calcitriol—osteoporosis	0.00031	0.00144	CcSEcCtD
Desipramine—Decreased appetite—Zoledronate—osteoporosis	0.00031	0.00144	CcSEcCtD
Desipramine—Agitation—Estradiol—osteoporosis	0.000309	0.00144	CcSEcCtD
Desipramine—Nausea—Estropipate—osteoporosis	0.000308	0.00143	CcSEcCtD
Desipramine—Body temperature increased—Pamidronate—osteoporosis	0.000308	0.00143	CcSEcCtD
Desipramine—Abdominal pain—Pamidronate—osteoporosis	0.000308	0.00143	CcSEcCtD
Desipramine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000308	0.00143	CcSEcCtD
Desipramine—Rash—Calcitriol—osteoporosis	0.000307	0.00143	CcSEcCtD
Desipramine—Fatigue—Zoledronate—osteoporosis	0.000307	0.00143	CcSEcCtD
Desipramine—Dermatitis—Calcitriol—osteoporosis	0.000307	0.00143	CcSEcCtD
Desipramine—Headache—Calcitriol—osteoporosis	0.000305	0.00142	CcSEcCtD
Desipramine—Somnolence—Conjugated Estrogens—osteoporosis	0.000305	0.00142	CcSEcCtD
Desipramine—Constipation—Zoledronate—osteoporosis	0.000305	0.00141	CcSEcCtD
Desipramine—Nausea—Alendronate—osteoporosis	0.000304	0.00141	CcSEcCtD
Desipramine—Malaise—Estradiol—osteoporosis	0.000303	0.00141	CcSEcCtD
Desipramine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000302	0.0014	CcSEcCtD
Desipramine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000302	0.0014	CcSEcCtD
Desipramine—Nausea—Raloxifene—osteoporosis	0.000299	0.00139	CcSEcCtD
Desipramine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000298	0.00138	CcSEcCtD
Desipramine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000298	0.00138	CcSEcCtD
Desipramine—Palpitations—Estradiol—osteoporosis	0.000297	0.00138	CcSEcCtD
Desipramine—Fatigue—Conjugated Estrogens—osteoporosis	0.000296	0.00137	CcSEcCtD
Desipramine—Nausea—Ibandronate—osteoporosis	0.000296	0.00137	CcSEcCtD
Desipramine—Asthenia—Risedronate—osteoporosis	0.000294	0.00137	CcSEcCtD
Desipramine—Feeling abnormal—Zoledronate—osteoporosis	0.000294	0.00136	CcSEcCtD
Desipramine—Constipation—Conjugated Estrogens—osteoporosis	0.000293	0.00136	CcSEcCtD
Desipramine—Hypertension—Estradiol—osteoporosis	0.00029	0.00135	CcSEcCtD
Desipramine—Pruritus—Risedronate—osteoporosis	0.00029	0.00135	CcSEcCtD
Desipramine—Nausea—Calcitriol—osteoporosis	0.000289	0.00134	CcSEcCtD
Desipramine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000288	0.00134	CcSEcCtD
Desipramine—Anxiety—Estradiol—osteoporosis	0.000285	0.00133	CcSEcCtD
Desipramine—Urticaria—Zoledronate—osteoporosis	0.000283	0.00131	CcSEcCtD
Desipramine—Discomfort—Estradiol—osteoporosis	0.000283	0.00131	CcSEcCtD
Desipramine—Abdominal pain—Zoledronate—osteoporosis	0.000282	0.00131	CcSEcCtD
Desipramine—Body temperature increased—Zoledronate—osteoporosis	0.000282	0.00131	CcSEcCtD
Desipramine—Diarrhoea—Risedronate—osteoporosis	0.000281	0.0013	CcSEcCtD
Desipramine—Dry mouth—Estradiol—osteoporosis	0.00028	0.0013	CcSEcCtD
Desipramine—Asthenia—Pamidronate—osteoporosis	0.00028	0.0013	CcSEcCtD
Desipramine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000278	0.00129	CcSEcCtD
Desipramine—Confusional state—Estradiol—osteoporosis	0.000277	0.00129	CcSEcCtD
Desipramine—Pruritus—Pamidronate—osteoporosis	0.000276	0.00128	CcSEcCtD
Desipramine—Oedema—Estradiol—osteoporosis	0.000274	0.00127	CcSEcCtD
Desipramine—Urticaria—Conjugated Estrogens—osteoporosis	0.000272	0.00127	CcSEcCtD
Desipramine—Dizziness—Risedronate—osteoporosis	0.000271	0.00126	CcSEcCtD
Desipramine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000271	0.00126	CcSEcCtD
Desipramine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000271	0.00126	CcSEcCtD
Desipramine—Tachycardia—Estradiol—osteoporosis	0.000268	0.00124	CcSEcCtD
Desipramine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000267	0.00124	CcSEcCtD
Desipramine—Diarrhoea—Pamidronate—osteoporosis	0.000267	0.00124	CcSEcCtD
Desipramine—Rash—Ethinyl Estradiol—osteoporosis	0.000265	0.00123	CcSEcCtD
Desipramine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000265	0.00123	CcSEcCtD
Desipramine—Headache—Ethinyl Estradiol—osteoporosis	0.000264	0.00122	CcSEcCtD
Desipramine—Vomiting—Risedronate—osteoporosis	0.000261	0.00121	CcSEcCtD
Desipramine—Rash—Risedronate—osteoporosis	0.000259	0.0012	CcSEcCtD
Desipramine—Dermatitis—Risedronate—osteoporosis	0.000258	0.0012	CcSEcCtD
Desipramine—Dizziness—Pamidronate—osteoporosis	0.000258	0.0012	CcSEcCtD
Desipramine—Headache—Risedronate—osteoporosis	0.000257	0.00119	CcSEcCtD
Desipramine—Asthenia—Zoledronate—osteoporosis	0.000256	0.00119	CcSEcCtD
Desipramine—Pruritus—Zoledronate—osteoporosis	0.000252	0.00117	CcSEcCtD
Desipramine—Nausea—Ethinyl Estradiol—osteoporosis	0.00025	0.00116	CcSEcCtD
Desipramine—Insomnia—Estradiol—osteoporosis	0.000248	0.00115	CcSEcCtD
Desipramine—Vomiting—Pamidronate—osteoporosis	0.000248	0.00115	CcSEcCtD
Desipramine—Paraesthesia—Estradiol—osteoporosis	0.000246	0.00114	CcSEcCtD
Desipramine—Asthenia—Conjugated Estrogens—osteoporosis	0.000246	0.00114	CcSEcCtD
Desipramine—Rash—Pamidronate—osteoporosis	0.000246	0.00114	CcSEcCtD
Desipramine—Dermatitis—Pamidronate—osteoporosis	0.000246	0.00114	CcSEcCtD
Desipramine—Headache—Pamidronate—osteoporosis	0.000244	0.00113	CcSEcCtD
Desipramine—Somnolence—Estradiol—osteoporosis	0.000244	0.00113	CcSEcCtD
Desipramine—Diarrhoea—Zoledronate—osteoporosis	0.000244	0.00113	CcSEcCtD
Desipramine—Nausea—Risedronate—osteoporosis	0.000244	0.00113	CcSEcCtD
Desipramine—Pruritus—Conjugated Estrogens—osteoporosis	0.000243	0.00113	CcSEcCtD
Desipramine—Dyspepsia—Estradiol—osteoporosis	0.000242	0.00112	CcSEcCtD
Desipramine—Decreased appetite—Estradiol—osteoporosis	0.000239	0.00111	CcSEcCtD
Desipramine—Fatigue—Estradiol—osteoporosis	0.000237	0.0011	CcSEcCtD
Desipramine—Dizziness—Zoledronate—osteoporosis	0.000236	0.00109	CcSEcCtD
Desipramine—Constipation—Estradiol—osteoporosis	0.000235	0.00109	CcSEcCtD
Desipramine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000235	0.00109	CcSEcCtD
Desipramine—Nausea—Pamidronate—osteoporosis	0.000232	0.00108	CcSEcCtD
Desipramine—Dizziness—Conjugated Estrogens—osteoporosis	0.000227	0.00105	CcSEcCtD
Desipramine—Vomiting—Zoledronate—osteoporosis	0.000226	0.00105	CcSEcCtD
Desipramine—Feeling abnormal—Estradiol—osteoporosis	0.000226	0.00105	CcSEcCtD
Desipramine—Rash—Zoledronate—osteoporosis	0.000225	0.00104	CcSEcCtD
Desipramine—Dermatitis—Zoledronate—osteoporosis	0.000224	0.00104	CcSEcCtD
Desipramine—Headache—Zoledronate—osteoporosis	0.000223	0.00104	CcSEcCtD
Desipramine—Vomiting—Conjugated Estrogens—osteoporosis	0.000218	0.00101	CcSEcCtD
Desipramine—Urticaria—Estradiol—osteoporosis	0.000218	0.00101	CcSEcCtD
Desipramine—Abdominal pain—Estradiol—osteoporosis	0.000217	0.00101	CcSEcCtD
Desipramine—Body temperature increased—Estradiol—osteoporosis	0.000217	0.00101	CcSEcCtD
Desipramine—Rash—Conjugated Estrogens—osteoporosis	0.000216	0.001	CcSEcCtD
Desipramine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000216	0.001	CcSEcCtD
Desipramine—Headache—Conjugated Estrogens—osteoporosis	0.000215	0.000998	CcSEcCtD
Desipramine—Nausea—Zoledronate—osteoporosis	0.000212	0.000983	CcSEcCtD
Desipramine—Nausea—Conjugated Estrogens—osteoporosis	0.000204	0.000946	CcSEcCtD
Desipramine—Asthenia—Estradiol—osteoporosis	0.000197	0.000915	CcSEcCtD
Desipramine—Pruritus—Estradiol—osteoporosis	0.000194	0.000902	CcSEcCtD
Desipramine—Diarrhoea—Estradiol—osteoporosis	0.000188	0.000872	CcSEcCtD
Desipramine—Dizziness—Estradiol—osteoporosis	0.000182	0.000843	CcSEcCtD
Desipramine—Vomiting—Estradiol—osteoporosis	0.000175	0.000811	CcSEcCtD
Desipramine—Rash—Estradiol—osteoporosis	0.000173	0.000804	CcSEcCtD
Desipramine—Dermatitis—Estradiol—osteoporosis	0.000173	0.000803	CcSEcCtD
Desipramine—Headache—Estradiol—osteoporosis	0.000172	0.000799	CcSEcCtD
Desipramine—Nausea—Estradiol—osteoporosis	0.000163	0.000757	CcSEcCtD
Desipramine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.3e-05	0.000136	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.3e-05	0.000136	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.3e-05	0.000136	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KL—osteoporosis	1.26e-05	0.000131	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IRS2—osteoporosis	1.25e-05	0.00013	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ADCY5—osteoporosis	1.24e-05	0.00013	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—GPX1—osteoporosis	1.24e-05	0.000129	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KL—osteoporosis	1.24e-05	0.000129	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000129	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.23e-05	0.000129	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—MTHFR—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KL—osteoporosis	1.22e-05	0.000128	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TPI1—osteoporosis	1.22e-05	0.000128	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—POMC—osteoporosis	1.22e-05	0.000128	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—LEP—osteoporosis	1.22e-05	0.000128	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—GPX1—osteoporosis	1.22e-05	0.000127	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KL—osteoporosis	1.21e-05	0.000127	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000126	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000126	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000125	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IRS2—osteoporosis	1.2e-05	0.000125	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.19e-05	0.000125	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.19e-05	0.000125	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.18e-05	0.000124	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.18e-05	0.000124	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.18e-05	0.000123	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000123	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—LEP—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.15e-05	0.000121	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—P4HB—osteoporosis	1.15e-05	0.00012	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ADCY5—osteoporosis	1.15e-05	0.00012	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	0.00012	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GPX1—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—MTHFR—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ENO1—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MTHFR—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000117	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.12e-05	0.000117	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ENO1—osteoporosis	1.11e-05	0.000116	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.11e-05	0.000116	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—IDH2—osteoporosis	1.11e-05	0.000116	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.11e-05	0.000116	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.1e-05	0.000115	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PSMA2—osteoporosis	1.1e-05	0.000115	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PSMA5—osteoporosis	1.1e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.09e-05	0.000114	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.000113	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.000113	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MTHFR—osteoporosis	1.06e-05	0.00011	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ENO1—osteoporosis	1.05e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—POMC—osteoporosis	1.05e-05	0.00011	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.04e-05	0.000109	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000108	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000108	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.02e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.02e-05	0.000107	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ACP5—osteoporosis	1.02e-05	0.000106	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.01e-05	0.000105	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—POMC—osteoporosis	1.01e-05	0.000105	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—LEP—osteoporosis	1e-05	0.000105	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IRS2—osteoporosis	1e-05	0.000105	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ADCY5—osteoporosis	9.87e-06	0.000103	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GPX1—osteoporosis	9.84e-06	0.000103	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ADCY5—osteoporosis	9.83e-06	0.000103	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—LEP—osteoporosis	9.81e-06	0.000102	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6R—osteoporosis	9.81e-06	0.000102	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—POMC—osteoporosis	9.8e-06	0.000102	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IRS2—osteoporosis	9.8e-06	0.000102	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IRS2—osteoporosis	9.75e-06	0.000102	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	9.68e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IGF1—osteoporosis	9.67e-06	0.000101	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ADCY5—osteoporosis	9.67e-06	0.000101	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ADCY5—osteoporosis	9.66e-06	0.000101	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GPX1—osteoporosis	9.63e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	9.62e-06	0.000101	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.6e-06	0.0001	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	9.59e-06	0.0001	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—LEP—osteoporosis	9.59e-06	0.0001	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ESR1—osteoporosis	9.57e-06	0.0001	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—LEP—osteoporosis	9.54e-06	9.97e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SPP1—osteoporosis	9.51e-06	9.94e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	9.5e-06	9.92e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TPI1—osteoporosis	9.45e-06	9.87e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ESR1—osteoporosis	9.36e-06	9.78e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SPP1—osteoporosis	9.36e-06	9.78e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SPP1—osteoporosis	9.34e-06	9.76e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SPP1—osteoporosis	9.31e-06	9.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SPP1—osteoporosis	9.28e-06	9.7e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SPP1—osteoporosis	9.19e-06	9.6e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ESR1—osteoporosis	9.16e-06	9.56e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—POMC—osteoporosis	9.14e-06	9.54e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.13e-06	9.54e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ESR1—osteoporosis	9.11e-06	9.52e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MTHFR—osteoporosis	9.08e-06	9.48e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—POMC—osteoporosis	9e-06	9.4e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IRS1—osteoporosis	8.94e-06	9.34e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP19A1—osteoporosis	8.91e-06	9.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ENO1—osteoporosis	8.9e-06	9.29e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MTHFR—osteoporosis	8.89e-06	9.29e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—P4HB—osteoporosis	8.89e-06	9.28e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PSMA2—osteoporosis	8.77e-06	9.16e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PSMA5—osteoporosis	8.77e-06	9.16e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IRS1—osteoporosis	8.75e-06	9.14e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GAPDH—osteoporosis	8.72e-06	9.11e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—POMC—osteoporosis	8.61e-06	9e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IRS2—osteoporosis	8.6e-06	8.99e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IRS1—osteoporosis	8.56e-06	8.94e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IRS1—osteoporosis	8.51e-06	8.89e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—RAP1A—osteoporosis	8.5e-06	8.87e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IRS2—osteoporosis	8.47e-06	8.84e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IRS2—osteoporosis	8.45e-06	8.82e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—POMC—osteoporosis	8.44e-06	8.82e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—POMC—osteoporosis	8.43e-06	8.8e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IRS2—osteoporosis	8.42e-06	8.8e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—LEP—osteoporosis	8.42e-06	8.8e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6R—osteoporosis	8.4e-06	8.78e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.4e-06	8.77e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IRS2—osteoporosis	8.39e-06	8.77e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IRS2—osteoporosis	8.31e-06	8.68e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—LEP—osteoporosis	8.29e-06	8.65e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IGF1—osteoporosis	8.29e-06	8.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—LEP—osteoporosis	8.27e-06	8.64e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—LEP—osteoporosis	8.24e-06	8.61e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—POMC—osteoporosis	8.24e-06	8.61e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6R—osteoporosis	8.22e-06	8.59e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—LEP—osteoporosis	8.21e-06	8.58e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—POMC—osteoporosis	8.2e-06	8.56e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—LEP—osteoporosis	8.13e-06	8.5e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IGF1—osteoporosis	8.1e-06	8.47e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ESR1—osteoporosis	8.04e-06	8.4e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6R—osteoporosis	8.04e-06	8.39e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6R—osteoporosis	8e-06	8.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IGF1—osteoporosis	7.92e-06	8.28e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ESR1—osteoporosis	7.91e-06	8.26e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ESR1—osteoporosis	7.89e-06	8.24e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.88e-06	8.24e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ESR1—osteoporosis	7.87e-06	8.22e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ESR1—osteoporosis	7.84e-06	8.19e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ESR1—osteoporosis	7.77e-06	8.11e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—osteoporosis	7.72e-06	8.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IRS1—osteoporosis	7.51e-06	7.85e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ADCY5—osteoporosis	7.46e-06	7.79e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GPX1—osteoporosis	7.43e-06	7.76e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—osteoporosis	7.4e-06	7.73e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IRS1—osteoporosis	7.39e-06	7.72e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IRS1—osteoporosis	7.38e-06	7.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IRS1—osteoporosis	7.35e-06	7.68e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IRS1—osteoporosis	7.33e-06	7.65e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ADCY5—osteoporosis	7.28e-06	7.6e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—POMC—osteoporosis	7.26e-06	7.58e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IRS1—osteoporosis	7.26e-06	7.58e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GPX1—osteoporosis	7.26e-06	7.58e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—POMC—osteoporosis	7.23e-06	7.56e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—POMC—osteoporosis	7.12e-06	7.43e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.11e-06	7.43e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—POMC—osteoporosis	7.11e-06	7.43e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—POMC—osteoporosis	7.1e-06	7.42e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—POMC—osteoporosis	7.08e-06	7.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—POMC—osteoporosis	7.06e-06	7.37e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6R—osteoporosis	7.06e-06	7.37e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—POMC—osteoporosis	6.99e-06	7.3e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF1—osteoporosis	6.96e-06	7.27e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6R—osteoporosis	6.94e-06	7.25e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6R—osteoporosis	6.93e-06	7.24e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.91e-06	7.21e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6R—osteoporosis	6.88e-06	7.19e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO1—osteoporosis	6.87e-06	7.17e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ADCY5—osteoporosis	6.86e-06	7.17e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MTHFR—osteoporosis	6.86e-06	7.17e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF1—osteoporosis	6.85e-06	7.15e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GPX1—osteoporosis	6.84e-06	7.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF1—osteoporosis	6.83e-06	7.14e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6R—osteoporosis	6.82e-06	7.12e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF1—osteoporosis	6.81e-06	7.11e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF1—osteoporosis	6.79e-06	7.09e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PSMA2—osteoporosis	6.77e-06	7.07e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PSMA5—osteoporosis	6.77e-06	7.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1—osteoporosis	6.72e-06	7.02e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—osteoporosis	6.7e-06	6.99e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—osteoporosis	6.34e-06	6.62e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—osteoporosis	6.31e-06	6.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—osteoporosis	6.2e-06	6.47e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—osteoporosis	6.07e-06	6.34e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—osteoporosis	6.06e-06	6.33e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	6.05e-06	6.32e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—osteoporosis	6.03e-06	6.3e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—osteoporosis	5.81e-06	6.07e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ADCY5—osteoporosis	5.81e-06	6.07e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	5.8e-06	6.06e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GPX1—osteoporosis	5.79e-06	6.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.49e-06	5.73e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—POMC—osteoporosis	5.49e-06	5.73e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—POMC—osteoporosis	5.36e-06	5.59e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—osteoporosis	5.35e-06	5.58e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—osteoporosis	5.32e-06	5.56e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.24e-06	5.47e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—osteoporosis	5.22e-06	5.46e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—osteoporosis	5.21e-06	5.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—osteoporosis	5.19e-06	5.42e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—osteoporosis	5.14e-06	5.37e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—POMC—osteoporosis	5.05e-06	5.27e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—osteoporosis	4.98e-06	5.2e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	4.97e-06	5.19e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—osteoporosis	4.87e-06	5.09e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	4.86e-06	5.08e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—osteoporosis	4.76e-06	4.97e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	4.75e-06	4.96e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—osteoporosis	4.74e-06	4.95e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.73e-06	4.94e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—osteoporosis	4.56e-06	4.77e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.49e-06	4.69e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX1—osteoporosis	4.47e-06	4.67e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—osteoporosis	4.37e-06	4.56e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—POMC—osteoporosis	4.27e-06	4.47e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—osteoporosis	4.18e-06	4.37e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.17e-06	4.36e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.13e-06	4.31e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—osteoporosis	4.11e-06	4.3e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—osteoporosis	4.11e-06	4.29e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.1e-06	4.29e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.1e-06	4.28e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—osteoporosis	4.09e-06	4.27e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	4.08e-06	4.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—osteoporosis	4.08e-06	4.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	4.07e-06	4.25e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—osteoporosis	4.04e-06	4.22e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	4.03e-06	4.21e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—osteoporosis	3.74e-06	3.91e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—osteoporosis	3.66e-06	3.82e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—osteoporosis	3.58e-06	3.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—osteoporosis	3.56e-06	3.72e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—POMC—osteoporosis	3.3e-06	3.45e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—osteoporosis	3.14e-06	3.28e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—osteoporosis	3.09e-06	3.23e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—osteoporosis	3.09e-06	3.22e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—osteoporosis	3.08e-06	3.21e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—osteoporosis	3.07e-06	3.2e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—osteoporosis	3.04e-06	3.17e-05	CbGpPWpGaD
